To include your compound in the COVID-19 Resource Center, submit it here.

AA4500: Phase III halted

AUXL temporarily suspended dosing in a double-blind, placebo-contolled, U.S. Phase III trial of AA4500 to treat Dupuytren's contracture in

Read the full 193 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE